ArticleNature communications2026
A primordial synaptotagmin-independent function of complexin in regulated exocytosis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glucose Transporters: Structure, Trafficking, Physiology, and Disease Relevance.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In Ca²⁺-triggered exocytosis such as synaptic neurotransmitter release, vesicle fusion is tightly regulated by synaptotagmin (Syt) and complexin (Cpx), which together clamp partially assembled SNARE complexes to prevent premature fusion. However, Cpx is evolutionarily more ancient than Syt, suggesting that it may also regulate exocytosis independently of Syt. To test this possibility, we sought to identify an extant exocytic pathway that requires Cpx but naturally lacks Syt. Here, we uncovered such a pathway - hormone-triggered exocytosis of glucose transporters in adipocytes. In this pathway, Cpx acts exclusively as a positive regulator, accelerating the evoked phase of exocytosis without affecting basal fusion. Mechanistically, this Syt-independent activity depends on the central helix of Cpx for SNARE binding and on its C-terminal membrane-binding peptide, which remodels the lipid bilayer to promote exocytosis. Our findings support a model in which Cpx originally evolved to accelerate exocytosis independently of Ca²⁺, enabling rapid mobilization of exocytic cargoes in response to environmental cues. With the later emergence of Syt, Cpx acquired an additional role - acting in concert with Syt to regulate Ca²⁺-triggered exocytosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.